Skip to content Skip to sidebar Skip to footer


MIT’s AI and Laser Duo Is Shaking Up How We Make Medicine

MIT-Takeda Program researchers have developed a physics and machine learning technique to enhance the manufacturing process of pharmaceutical pills and powders. Their method, called PEACE, involves using a laser and machine learning to measure particle size distribution, increasing efficiency, reducing failed batches, and making the process more sustainable and cost-effective. A collaborative research team…

Read More

[KBR Exclusive: Inside Boston Biocluster] Transforming R&D strategy and embracing innovation: Takeda R&D chief

BOSTON, Mass. -- By Lee Han-soo/Korea Biomedical Review correspondent -- Takeda Pharmaceuticals, the first Asian-based company to secure a spot among the 10 largest global pharma companies by sales, has redefined its research and development (R&D) strategy for groundbreaking discoveries and cutting-edge therapies, the company’s head of R&D said. Korea Biomedical Review met with Andy…

Read More

Arzeda, the Protein Design Company™, Announces Collaboration with Takeda to Accelerate Protein Biologics Optimization

SEATTLE , March 21, 2023 /PRNewswire/ -- Arzeda, the industry-leading Protein Design Company™, announced a collaboration with Takeda aimed at deploying AI-based protein design to optimize the properties of protein biologics. The collaboration will allow Takeda to leverage Arzeda's Intelligent Protein Design Technology™, which has the potential to accelerate the optimization of proteins…

Read More

MIT-Takeda Program heads into fourth year with crop of 10 new projects | MIT News

In 2020, the School of Engineering and Takeda Pharmaceutical Company launched the MIT-Takeda Program, which aims to leverage the experience of both entities to solve problems at the intersection of health care, medicine, and artificial intelligence. Since the program began, teams have devised mechanisms to reduce manufacturing time for certain pharmaceutical products, submitted a patent…

Read More

2022-23 Takeda Fellows: Leveraging AI to positively impact human health | MIT News

The MIT-Takeda Program, a collaboration between MIT’s School of Engineering and Takeda Pharmaceuticals Company, fuels the development and application of artificial intelligence capabilities to benefit human health and drug development. Part of the Abdul Latif Jameel Clinic for Machine Learning in Health, the program coalesces disparate disciplines, merges theory and practical implementation, combines algorithm and…

Read More